Genetic deletion of calcium/calmodulin-dependent protein kinase kinase β (CaMKK β) or CaMK IV exacerbates stroke outcomes in ovariectomized (OVXed) female mice

BMC Neuroscience

Volumn 15, Issue 1, 2014, Pages

  Liu, Lin ^a   McCullough, Louise ^a   Li, Jun ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

CaMK IV; CaMKK ; Inflammation; Sex differences; Stroke

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE BETA; COLLAGEN TYPE 4; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GELATINASE B; INTERLEUKIN 6; PROTEIN BCL 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CAMK4 PROTEIN, MOUSE; CAMKK2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FUNCTIONAL STATUS; GENE DELETION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; OVARIECTOMY; SEX DIFFERENCE; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DEFICIENCY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SEXUAL DEVELOPMENT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 4; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; FEMALE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVARIECTOMY; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; STROKE;

EID: 84965188721     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/s12868-014-0118-2     Document Type: Article

References (28)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER III, Moy CS, et al: Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014, 129:e28-e292.
2. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, American Heart Association Stroke Council: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator a science advisory from the American Heart Association/American Stroke Association. Stroke 2009, 40:2945-2948.
3. Manwani B, McCullough LD: Sexual dimorphism in ischemic stroke: lessons from the laboratory. Womens Health (Lond Engl) 2011, 7:319-339.
4. Li J, Benashski SE, Siegel C, Liu F, McCullough LD: Adenosine monophosphate activated protein kinase inhibition is protective in both sexes after experimental stroke. Neurosci Lett 2010, 482:62-65.
5. Yuan M, Siegel C, Zeng Z, Li J, Liu F, McCullough LD: Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke. Exp Neurol 2009, 217:210-218.
6. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH, STAIR Group: Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40:2244-2250.
7. Clayton JA, Collins FS: Policy: NIH to balance sex in cell and animal studies. Nature 2014, 509:282-283.
8. Soderling TR: The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem Sci 1999, 24:232-236.
9. McCullough LD, Tarabishy S, Liu L, Benashski S, Xu Y, Ribar T, Means A, Li J: Inhibition of calcium/calmodulin-dependent protein kinase kinase ß and calcium/calmodulin-dependent protein kinase IV is detrimental in cerebral ischemia. Stroke 2013, 44:2559-2566.
10. Mizuno K, Antunes-Martins A, Ris L, Peters M, Godaux E, Giese KP: Calcium/calmodulin kinase kinase beta has a male-specific role in memory formation. Neuroscience 2007, 145:393-402.
11. Li J, Siegel M, Yuan M, Zeng Z, Finnucan L, Persky R, Hurn PD, McCullough LD: Estrogen enhances neurogenesis and behavioral recovery after stroke. J Cereb Blood Flow Metab 2011, 31:413-425.
12. Liu L, Doran S, Xu Y, Manwani B, Ritzel R, Benashski S, McCullough L, Li J: Inhibition of mitogen-activated protein kinase phosphatase-1 (MKP-1) increases experimental stroke injury. Exp Neurol 2014, in press.
13. Li J, Benashski SE, Venna VR, McCullough LD: Effects of metformin in experimental stroke. Stroke 2010, 41:2645-2652.
14. Sée V, Boutillier AL, Bito H, Loeffler JP: Calcium/calmodulin-dependent protein kinase type IV (CaMKIV) inhibits apoptosis induced by potassium deprivation in cerebellar granule neurons. FASEB J 2001, 15:134-144.
15. Besancon E, Guo S, Lok J, Tymianski M, Lo EH: Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death instroke. Trends Pharmacol Sci 2008, 29:268-275.
16. Nicotera P: Molecular switches deciding the death of injured neurons. Toxicol Sci 2003, 74:4-9.
17. Cheng YD, Al-Khoury L, Zivin JA: Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 2004, 1:36-45.
18. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S: Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004, 56:468-677.
19. Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS, Kusnecov A, Herrup K: Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med 2012, 18:783-790.
20. Paroni G, Fontanini A, Cernotta N, Foti C, Gupta MP, Yang XJ, Fasino D, Brancolini C: Dephosphorylation and caspase processing generate distinct nuclear pools of histone deacetylase 4. Mol Cell Biol 2007, 27:6718-6732.
21. Kitagawa K: CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J 2007, 274:3210-3217.
22. Kane CD, Means AR: Activation of orphan receptor-mediated transcription by Ca(2+)/calmodulin-dependent protein kinase IV. EMBO J 2000, 19:691-701.
23. Ermisch M, Firla B, Steinhilber D: Protein kinase A activates and phosphorylates RORa4 in vitro and takes part in RORa activation by CaMK-IV. Biochem Biophys Res Commun 2011, 408:442-446.
24. Racioppi L, Means AR: Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller. Trends Immunol 2008, 29:600-607.
25. Anderson KA, Ribar TJ, Lin F, Noeldner PK, Green MF, Muehlbauer MJ, Witters LA, Kemp BE, Means AR: Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab 2008, 7:377-388.
26. Dzhagalov I, Giguère V, He YW: Lymphocyte development and function in the absence of retinoic acid-related orphan receptor alpha. J Immunol 2004, 173:2952-2959.
27. Kopmels B, Mariani J, Delhaye-Bouchaud N, Audibert F, Fradelizi D, Wollman EE: Evidence for a hyperexcitability state of staggerer mutant mice macrophages. J Neurochem 1992, 58:192-199.
28. Mizuno K, Ris L, Sánchez-Capelo A, Godaux E, Giese KP: Ca2+/calmodulin kinase kinase alpha is dispensable for brain development but is required for distinct memories in male, though not in female, mice. Mol Cell Biol 2006, 26:9094-9104.